Versigent officer trust plans $10.4M share sale
A trust associated with an officer plans to sell 220,000 Versigent PLC shares under a Rule 10b5-1 trading plan through Goldman Sachs.
Rhea-AI Filing Summary
Versigent PLC (VGNT) has a planned secondary sale of common stock by an affiliate. A total of 220,000 shares of Versigent common stock, with an aggregate market value of $10,425,800, are to be sold on the NYSE through Goldman Sachs & Co. LLC on behalf of the Kevin P. Clark 2002 Revocable Trust. The notice states that these sales are made under a selling plan dated June 3, 2026 intended to comply with Rule 10b5-1(c). Versigent had 70,835,265 shares outstanding of common stock at the time referenced.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 220,000 shares
Aggregate market value of shares: $10,425,800
Shares outstanding: 70,835,265 shares
+3 more
6 metrics
Shares to be sold
220,000 shares
Common stock to be sold under the Form 144 notice
Aggregate market value of shares
$10,425,800
Market value of the 220,000 Versigent common shares covered by the notice
Shares outstanding
70,835,265 shares
Versigent common stock outstanding at the time referenced
Planned sale date
September 8, 2026
Date associated with the planned NYSE sale of the shares
Rule 10b5-1 selling plan date
June 3, 2026
Date of the selling plan intended to comply with Rule 10b5-1(c)
Number of compensation grants listed
13 grants
Separate executive compensation common stock entries from 2014 to 2026
Key Terms
Rule 144, Rule 10b5-1(c), selling plan, Revocable Trust
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Rule 10b5-1(c) regulatory
"a selling plan dated 06/03/2026 that is intended to comply with Rule 10b5-1(c)."
Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.
selling plan financial
"made in connection with a selling plan dated 06/03/2026"
Revocable Trust financial
"220,000 shares to be sold by Kevin P. Clark 2002 Revocable Trust."
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
FAQ
What does Versigent PLC (VGNT) disclose in this Form 144?
The filing discloses a planned sale of 220,000 shares of Versigent PLC common stock on the NYSE by the Kevin P. Clark 2002 Revocable Trust, with an aggregate market value of $10,425,800, acting through Goldman Sachs & Co. LLC.
What is the relationship of the seller to Versigent PLC (VGNT)?
The seller is identified as the Kevin Clark account, with the role indicated as Officer. The shares to be sold are held by the Kevin P. Clark 2002 Revocable Trust and were originally acquired as executive compensation on multiple dates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
